Bank of America Corporation »

Lyell Immunopharma shares owned by Bank of America Corporation

Quarter-by-quarter ownership of Lyell Immunopharma (LYEL) shares owned by Bank of America Corporation from 13F filings

Historical chart of Bank of America Corporation investment in Lyell Immunopharma

Tip: Access up to 7 years of quarterly data

All positions including Lyell Immunopharma held by Bank of America Corporation consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Lyell Immunopharma by Bank of America Corporation

Quarter filed Position value Share count Share price at filing
2026-03-31 $668k 33k 20.06

More positions owned by Bank of America Corporation

NVIDIA Corporation (NVDA)
Apple (AAPL)
Microsoft Corporation (MSFT)
Vanguard Index Fds Value Etf (VTV)
Vanguard Index Fds Growth Etf (VUG)
State Str Spdr S&p 500 Etf T Tr Unit (SPY)
Alphabet Cap Stk Cl A (GOOGL)
JPMorgan Chase & Co. (JPM)
Ishares Tr Core Msci Eafe (IEFA)
Broadcom (AVGO)
Amazon (AMZN)
Vanguard Index Fds S&p 500 Etf Shs (VOO)
Ishares Core Msci Emkt (IEMG)
Ishares Tr Core S&p500 Etf (IVV)
Vanguard Tax-managed Fds Van Ftse Dev Mkt (VEA)

View all positions for Bank of America Corporation

Top funds holding Lyell Immunopharma

Arch Venture Corp
Vanguard Group
Foresite Capital Management IV
Orland Properties
Vanguard Capital Management
Almitas Capital
Foresite Capital Management V
Millennium Management
Citadel Advisors
venBio Partners
Susquehanna International
Alphabet
BlackRock
Geode Capital Management
Sc China Holding

View all funds holding Lyell Immunopharma